Rise and shine, another day has arrived. And we are happy to say that so have we. After an unexpected two-day disappearance due to technical problems, we have returned as fresh as ever. So while we brew the mandatory cup of stimulation in the official Pharmalot cafeteria, please join us as we peruse the news of the world. Have a great day, everyone, and stay in touch...
Will Bristol-Myers Buy Actelion? (Reuters)
Health Care Fraud In Europe Is Rising (PharmaTimes)
China's API Suppliers May Have A Bright Future (OutsourcingPharma)
Controversy Erupts Over Gout Drug Price Hike (MedPage Today)
Vical Signs Deal To Make HIV Vaccine (Associated Press)
Novo Nordisk Invests $73M Into US Plant Expansion (InPharma-Technologist)